期刊文献+

小剂量卡维地洛治疗重度充血性心力衰竭短期临床观察 被引量:3

LOW-DOSE CARVEDILOL IN SEVERE CONGESTIVE HEART FAILURE
下载PDF
导出
摘要 目的 观察小剂量卡维地洛治疗重度充血性心力衰竭 (CHF)的临床耐受性和安全性。方法  2 8例重度CHF患者在标准治疗基础上 (利尿剂、血管紧张素转换酶抑制剂 (ACEI)和洋地黄类制剂等 )加用卡维地洛 ,起始剂量 3.12 5mg ,2 /d ,2周后增至 6 .2 5mg ,2 /d ,维持 3个月 ,治疗前后分别对患者心功能 (NYHA分级法 )、血压、心率、及生化指标进行检测 ,以评价小剂量卡维地洛治疗重度CHF的耐受性、安全性及疗效。结果 应用小剂量卡维地洛治疗 3个月后患者心功能较治疗前改善 ,12例心功能由Ⅲ、Ⅳ级改善为Ⅱ级 ,心率、左心室舒张末期压下降 ,不良反应少 ,对肝肾功能、血糖、血脂、血常规均无影响 ,耐受性好。结论 小剂量卡维地洛治疗重症CHF短期疗效。 Objective To observe tolerance and safety of low-dose carvedilol in patients with severe congestive heart failure. Methods Carvedilol was added on basic standard therapy in 28 patients beginning with dosage of 3.125mg bid,and which,two weeks later,increased to 6.25mg bid till 3 months after.Before and after treatment with carvedilol,NYHA class,signs including blood pressure and heart rate,laboratory test were performed. Results After treatment with low-dose carvedilol,NYHA class was improved,12 patients improved from class Ⅲ、Ⅳ to class Ⅱ(efficiency was 42.8%),none became worsen,adverse events were seldom observed,blood routine,liver,renal function weren't changed,all patients can tolerate low-dose carvedilol. Conclusion Low-dose carvedilol is effective and safe in the treatment of severe CHF patients with good tolerance.
出处 《中国心血管病研究》 CAS 2004年第7期513-515,共3页 Chinese Journal of Cardiovascular Research
关键词 心力衰竭 充血性 Β受体阻滞剂 卡维地洛 heart failure,congestive βadrenoceptor blocker carvedilol
  • 相关文献

参考文献8

  • 1[1]Hjalmarson A, Goldstein S, Fagerberg B, et al. Effects of conntrolled- release metoprolol on mortality, hospitalizations, and well- being in patients with heart failure: The metoprolol CR/XL randomized intervention trial in congestive heart failure ( MERIT - HF). MERIT- HF study group[J]. JAMA, 2000, 283 :1295-1302
  • 2[2]The CAPRICORN Investagators. Effects of carvedilol on outcome of myocardial infarction in patients with left ventricular dysfunction: the CAPRICORN randomised trial[J ]. Lancet,2001,357:1385- 1390
  • 3[3]Jrimm W, Maisch B. Sudden cardiac death in dilated ardialmyopathy - therapeutic obtions [ J ]. Hearc,2002,27 (8): 750 - 759
  • 4[4]Packer M,Coats A J, Fowler MB, et al. Effect of carvedilol on survival in severe chronic heart failure [ J ]. N Engl J Med,2001,344:1651 - 1658
  • 5[5]Talazzuoli A,Carrera A, Calabria T, et al. Effect of carvedilol therapy on restrictive diastolic filling pattern in chronic heart failure [ J ]. Am Heart J, 2004, 147 ( 1 ):ER
  • 6[6]Gupta R, Tang WH, Yong J B, et al. Patterns of betablocker utilization in patients with chronic heart failure:exterience from a stecialized outpatients heart clinic[J]. Am heart J ,2004Jan, 147(1) :79 - 83
  • 7[7]Meng A, Yoshikawa T, Baba A, et al. Beta - blockers are effective in congestive heart failure patients with atrial fibrilation[ J ]. J Card Fail, 2003,9 (5): 398 - 403
  • 8[8]Bristow MR,Gilbert EM,Abraham WT,et al. Carvedilol produces dose- related improvement in left ventricular function and survival in subjects with chronic heart failure[ J ]. Circulation, 1996,94: 2807 - 2816

同被引文献8

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部